Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus

Article Abstract:

Endothelial dysfunction predicts type 2 diabetes in women independent of other known risk factors, including obesity and subclinical inflammation. Patients with type 2 diabetes have elevated plasma levels of biomarkers reflecting endothelial dysfunction, but whether these abnormalities exist prior to the development of diabetes is not known.

Endothelium

---

Coffee consumption and risk of type 2 diabetes

Article Abstract:

A study is conducted to examine the association between habitual coffee consumption and risk of type 2 diabetes and related outcomes. It is concluded that the systematic review supports the hypothesis that habitual coffee consumption is associated with a substantially lower risk of type 2 diabetes.

Roasted coffee, Processed Coffee, Coffee and Tea Manufacturing, Coffee (Beverage), Coffee

---

Body iron stores in relation to risk of type 2 diabetes in apparently healthy women

Article Abstract:

The plasma ferritin concentration and the ratio of the concentration of transferrin receptors to ferritin in relation to risk of type 2 diabetes is investigated. The higher iron store reflects an increased risk of type 2 diabetes in healthy women independent of known diabetes risk factors.

Science & research, Research, Influence, Transferrin, Women's health, Ferritin

Similar abstracts:

• Abstracts: Patients, physicians fall short in optimal prevention of diabetes complications. Dash of dissent on salt intake advice
• Abstracts: Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults
• Abstracts: Bioterror vaccine production: Take 2: New biodefence R&D agency created
• Abstracts: Deadly fish, tainted toothpaste spur scrutiny of products from China. Experts weigh in on promotion, prescription of off-label drugs
• Abstracts: HER-2 testing in breast cancer using parallel tissue-based methods. High-quality HER-2 testing: setting a standard for oncologic biomaker assessment

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.